Thierry T. Diagana

Also affiliated with Novant Health, Novartis (China), NovaBay Pharmaceuticals (United States)

MedicineComputer Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Use-case scenarios for an anti-Cryptosporidium therapeutic”.

Use-case scenarios for an anti-Cryptosporidium therapeutic

PLoS neglected tropical diseases(2021)10.1371/journal.pntd.0009057

N/A

0DataRank · unranked

50 citations

Susan Shepherd, Kevin Steiner, Beatrice Amadi, Natasha Aziz, Ujjini H. Manjunatha +4 more

Discovery and Preclinical Pharmacology of INE963, a Potent and Fast-Acting Blood-Stage Antimalarial with a High Barrier to Resistance and Potential for Single-Dose Cures in Uncomplicated Malaria

Journal of Medicinal Chemistry(2022)10.1021/acs.jmedchem.1c01995

N/A

0DataRank · unranked

32 citations

Fumiaki Yokokawa, Tom Kirrane, Anne-Catherine Mata, Richard S.P. Huang, Nicole Blaquière +39 more

Identification of Potent, Broad-Spectrum Coronavirus Main Protease Inhibitors for Pandemic Preparedness

Journal of Medicinal Chemistry(2024)10.1021/acs.jmedchem.4c01404

N/A

0DataRank · unranked

13 citations

Keira Garland, Lei Zhang, Richard T. Eastman, Matthew J. Hesse, Mark Knapp +23 more